Meinian Onehealth Hits Day Low at CNY 5.76 Amid Price Pressure

Meinian Onehealth Healthcare Holdings Co., Ltd. experienced a notable decline today, with the stock dropping by 5.1% and reaching an intraday low of CNY 5.76. This performance stands in contrast to the China Shanghai Composite, which fell by 2.04% on the same day. Over the past week, Meinian Onehealth has seen a decrease of 5.87%, while its one-month performance remains positive at 9.07%. Despite a year-to-date performance of 9.28%, the company has faced challenges, including a significant drop in net profit and pre-tax profit in its latest quarterly results. The net profit for March 2026 was reported at CNY -249.87 million, marking a decline of 479.44%. Additionally, net sales reached their lowest at CNY 1,583.79 million. The company's financial metrics indicate a return on equity of 4.85% and a price-to-book ratio of 3.02, suggesting a relatively high valuation. With a market capitalization of CNY 23,863 million, Meinian Onehealth operates within the pharmaceuticals and biotechnology sector, where it has shown mixed performance trends over the past several years.